News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Cambria Biosciences Unveils Novel Epilepsy Drug Discovery Program at the Neurotechnology Industry Organization Conference



5/18/2007 2:23:16 AM

WOBURN, Mass.--(BUSINESS WIRE)--Cambria Biosciences today unveiled a novel approach to discovering epilepsy drugs by utilizing an intact animal nervous system engineered for high-throughput screening. The process was described in a presentation made by Dr. Leo Liu, President and Chief Executive Officer at Cambria, at the 2nd Annual Neurotechnology Industry Organization Conference. The Company is currently using this discovery platform to build a pipeline of new epilepsy drug leads.

Read at BioSpace.com


comments powered by Disqus
   
Epilepsy

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES